The 20 Best Graves Disease Doctors Near Me in Ann Arbor, MI

Terry Smith is an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Smith is rated as an Elite provider by MediFind in the treatment of Graves Disease. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Graves Disease, Hyperthyroidism, Thyroid Eye Disease, Thyroid Storm, and Thyroidectomy.

Victor Elner is a Pathologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Elner is rated as a Distinguished provider by MediFind in the treatment of Graves Disease. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Graves Disease, Melanoma of the Eye, Entropion, and Isolated Duane Retraction Syndrome.

Vinay Aakalu is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Aakalu is rated as a Distinguished provider by MediFind in the treatment of Graves Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Ptosis, Eyelid Drooping, Blocked Tear Duct, and Graves Disease.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Advanced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Advanced provider by MediFind in the treatment of Graves Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Advanced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Advanced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Gogineni is rated as an Advanced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Dr. Nwagwu received her medical degree from the University of Lagos-Nigeria, College of Medicine, 2004. She completed a Family Medicine residency at St. Mary Mercy Hospital, Livonia Michigan (part of Trinity Health System) in 2013, and a Geriatric Medicine fellowship at University of Michigan in 2014. She pursued an additional certification in wound care through the American Board of Wound Management in 2020. She is board certified in Family medicine, Geriatric medicine and Wound care.Her special interests include Geriatric primary care, Ambulatory clinics, Preventive medicine/ Wellness, Post-acute care ( subacute rehab care), Geriatric wound care/ wound care education , patient education as well as education for medical learners and trainees at various levels. Dr. Nwagwu is rated as a Distinguished provider by MediFind in the treatment of Graves Disease. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Graves Disease, Thyroid Storm, Enlarged Prostate (BPH), and Type 2 Diabetes (T2D). Dr. Nwagwu is board certified in Family Medicine and Geriatric Medicine.

Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Graves Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma. Dr. Hammer is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Experienced provider by MediFind in the treatment of Graves Disease. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Yu Kuei Alex Lin is a Clinical Assistant Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). After earning his medical degree at Poznan University of Medical Sciences, Poland, he completed his Medicine Residency at Beth Israel Medical Center, NY, and Endocrinology fellowship at Cleveland Clinic, OH. Dr. Lin joined the faculty at Michigan in 2019.Dr. Lin is a clinical diabetes researcher with research focuses on characterizing hypoglycemia (including evaluating impaired awareness of hypoglycemia and unhelpful hypoglycemia beliefs and management behaviors and their associations with hypoglycemia developments) and devising and testing behavioral interventions for improving hypoglycemia self-management. Dr. Lin’s clinical practice focuses on diabetes and general endocrinology. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Graves Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Pancreatectomy, and Islet Cell Transplantation. Dr. Lin is board certified in Endocrinology, Diabetes & Metabolism.

Eric Buras is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Buras is rated as an Experienced provider by MediFind in the treatment of Graves Disease. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Neurohypophyseal Diabetes Insipidus, Panhypopituitarism, and Diabetes Insipidus (DI).

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Papaleontiou is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Melda Ince is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Ince is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Congenital Generalized Lipodystrophy, Autosomal Dominant Hypocalcemia, Graves Disease, and Thyroid Storm.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Daniyeh Khurram is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Khurram is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, Thrombectomy, and Endoscopy. Dr. Khurram is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Iyengar is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy. Dr. Ajluni is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Graves Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.